GEMVAX KAEL CO LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024 2024-10-29 19:27
GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019 2019-12-11 18:40
1